Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kunal Ranjan Vinayak
Observed names:
Kunal R Vinayak,
Kunal R. Vinayak
Institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Mahamana Pandit Madan Mohan Malaviya Cancer Centre
Observed institutions:
Homi Bhabha National Institute,
Tata Memorial Hospital,
Dr. D. Y. Patil Medical College, Hospital and Research Centre,
Dr. D.Y. Patil Vidyapeeth, Pune,
Mahamana Pandit Madan Mohan Malaviya Cancer Centre
ORCID:
0009-0008-1114-0566
Observed ORCID:
0009-0008-1114-0566
OpenAlex ID:
A5113307795
Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)
2025
·
Akhil Kapoor
, Anuj Gupta
, et al.
·
JCO Global Oncology
·
13
At Crossroads: The Challenges for Geriatric Oncology in India
2024
·
Bipinesh Sansar
, Anuj Gupta
, et al.
·
South Asian Journal of Cancer
·
8
Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients
2025
·
Anuj Gupta
, Bipinesh Sansar
, et al.
·
Scientific Reports
·
7
PDF
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers
2024
·
Anant Ramaswamy
, Prabhat Bhargava
, et al.
·
JNCI Cancer Spectrum
·
7
PDF
Unravelling Eribulin’s role in metastatic breast cancer: evaluating benefits for both triple negative and non-triple negative patients in real-world scenarios in resource-constrained settings
2024
·
Akhil Kapoor
, Anuj Gupta
, et al.
·
ecancermedicalscience
·
4
A phase III randomized, open-label study to establish the superiority of triple oral metronomic therapy (OMCT) used in addition to chemotherapy regimen (paclitaxel + carboplatin) over chemotherapy alone for the treatment of advanced unresectable head and neck cancer squamous cell cancer (HNSCC).
2024
·
Akhil Kapoor
, Anuj Gupta
, et al.
·
Journal of Clinical Oncology
·
3
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).
2026
·
Akhil Kapoor
, Anuj Gupta
, et al.
·
PubMed
·
2
Pediatric Palliative Care: A Retrospective Review from a Tertiary Cancer Center in North-Central India
2026
·
Pallavi Singh
, Somnath Dey
, et al.
·
Indian Journal of Medical and Paediatric Oncology
·
1
PDF
Unraveling the Burden Faced and Analyzing Coping Strategies Used by Caregivers in Pediatric Palliative Cancer Care: A Tertiary Cancer Center-Based Study in Uttar Pradesh, India: A Cross-Sectional Study
2026
·
Kunal Ranjan Vinayak
, Somnath Dey
, et al.
·
Indian Journal of Medical and Paediatric Oncology
Impact of combined positive score in cetuximab plus chemotherapy in recurrent/metastatic head and neck cancer: A real-world study
2026
·
Akhil Kapoor
, Kaushal Patel
, et al.
·
South Asian Journal of Cancer
PDF
Metastatic Uterine Sarcomas: A Retrospective Analysis on Clinical Outcomes and Biology
2026
·
Neha Singh
, Ankita Rungta Kapoor
, et al.
·
Cureus
PDF
Impact of CPS on Indian Recurrent/Metastasis Oral Cavity Patients Treated with Cetuximab Plus Chemotherapy: A Real-World Study
2026
·
Akhil Kapoor
, Kaushal Patel
, et al.
·
Indian Journal of Medical and Paediatric Oncology
Real-World Outcomes in Indian Patients with Recurrent or Metastatic Head and Neck Cancer Treated with Erbitux and Chemotherapy: Impact of CPS Score (RACE-Head Neck India)
2026
·
Kaushal Patel
, Akhil Kapoor
, et al.
·
Indian Journal of Medical and Paediatric Oncology
Persistent Thrombocytopenia of an Unexplained Cause in a Patient With Metastatic Renal Cell Carcinoma: A Case Report
2024
·
Nidhi Shree
, Somnath Dey
, et al.
·
Cureus
PDF
Show more works
View as search
Works count:
14
Citation count:
45
H-index:
4
I10-index:
1
Year
Topic
Type